ARTICLE | Clinical News
ThermoDox heat-activated liposome regulatory update
November 22, 2010 8:00 AM UTC
The COMP issued a positive opinion to grant Orphan Drug designation for Celsion's ThermoDox to treat hepatocellular carcinoma (HCC). The heat-activated liposome encapsulating doxorubicin is in Phase I...